STXS - Stereotaxis, Inc.

Other OTC - Other OTC Delayed Price. Currency in USD
0.83
0.00 (0.00%)
As of 10:27AM EDT. Market open.
Stock chart is not supported by your current browser
Previous Close0.83
Open0.85
Bid0.00 x 0
Ask0.00 x 0
Day's Range0.81 - 0.85
52 Week Range0.51 - 1.10
Volume11,286
Avg. Volume40,661
Market Cap48.905M
Beta1.59
PE Ratio (TTM)N/A
EPS (TTM)-0.32
Earnings DateAug 8, 2018 - Aug 13, 2018
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • GlobeNewswire3 hours ago

    Stereotaxis to Present at 8th Annual LD Micro Invitational

    Stereotaxis, Inc. (STXS), the global leader in innovative robotic technologies for the treatment of cardiac arrhythmias, today announced that David Fischel, Chairman and Chief Executive Officer, is scheduled to present at the 8th Annual LD Micro Invitational. Mr. Fischel will provide an overview of the Company's technology and business during his presentation on Monday, June 4, 2018 at 7:00 a.m. PT. In addition, he will be available to participate in one-on-one meetings with investors and other conference attendees, which can be scheduled at www.ldmicro.com/events. The conference will be held at the Luxe Sunset Bel Air Hotel, will feature 230 companies in the small-cap/micro-cap space, and will be attended by over 1,000 individuals.

  • Thomson Reuters StreetEvents12 hours ago

    Edited Transcript of STXS earnings conference call or presentation 14-May-18 2:00pm GMT

    Q1 2018 Stereotaxis Inc Earnings Call

  • GlobeNewswire8 days ago

    Stereotaxis Reports 2018 First Quarter Financial Results

    3% year-over-year growth in recurring revenue Continued progress on strategic innovation initiatives; collaboration with Acutus Medical Increasing quantity and quality of peer-reviewed clinical validation ...

  • ACCESSWIRE8 days ago

    Stereotaxis, Inc. to Host Earnings Call

    NEW YORK, NY / ACCESSWIRE / May 14, 2018 / Stereotaxis, Inc. (NASDAQ: STXS ) will be discussing their earnings results in their Q1 Earnings Call to be held on May 14, 2018 at 10:00 AM Eastern Time. To ...

  • GlobeNewswire18 days ago

    Stereotaxis to Highlight Unique Advantages of Robotic Cardiac Ablation at Heart Rhythm 2018

    Stereotaxis, Inc. (STXS), the global leader in innovative robotic technologies for the treatment of cardiac arrhythmias, announced today that it will participate in the annual Heart Rhythm Society (HRS) Scientific Sessions at the Boston Convention & Exhibition Center from May 9-12. On Wednesday, May 9, the independent physician-led Society for Cardiac Robotic Navigation will host a symposium to review clinical applications, best practices, and clinical research related to robotic magnetic navigation in electrophysiology. The Stereotaxis booth will include interactive features that demonstrate the unique experience and capabilities provided by robotic magnetic navigation including navigation simulators, a virtual reality robotic lab, and a hands-on robotic catheter demonstration.

  • GlobeNewswire18 days ago

    Stereotaxis to Report First Quarter 2018 Financial Results on May 14, 2018

    LOUIS, May 04, 2018-- Stereotaxis, Inc., the global leader in innovative robotic technologies for the treatment of cardiac arrhythmias, today announced that it will release financial results for its 2018 ...

  • GlobeNewswire19 days ago

    Stereotaxis and Acutus Medical Announce Strategic Collaboration

    Stereotaxis (STXS), the global leader in innovative robotic technologies for the treatment of cardiac arrhythmias, and Acutus Medical, a global heart rhythm technology company transforming the way electrophysiologists map complex cardiac arrhythmias, announced today a strategic collaboration to integrate the Stereotaxis Niobe® Magnetic Navigation System and the Acutus Medical AcQMap® High Resolution Imaging and Mapping System with the goal of improving patient care and the physician experience in electrophysiology. “I was very excited to perform the first procedures using these two technologies together.

  • GlobeNewswire21 days ago

    Stereotaxis Announces Publication of Clinical Research Supplement Highlighting Robotic Navigation for Cardiac Arrhythmias

    Stereotaxis, Inc. (STXS), the global leader in innovative robotic technologies for the treatment of cardiac arrhythmias, today announced that the Society for Cardiac Robotic Navigation (SCRN) has published a supplement in the European Journal of Pacing, Arrhythmias and Cardiac Electrophysiology of the European Heart Rhythm Association and the European Society of Cardiology (EP Europace). The title of the supplement is “Update on Clinical Applications for Robotic Magnetic Navigation for Cardiac Arrhythmia” and can be accessed at https://academic.oup.com/europace/issue/20/suppl_2.

  • GlobeNewswirelast month

    Stereotaxis Announces Expanded European Labeling for Navigation in the Pericardial Space

    LOUIS, April 11, 2018-- Stereotaxis, Inc., the global leader in innovative robotic technologies for the treatment of cardiac arrhythmias, today announced that navigation in the pericardial space has been ...

  • Thomson Reuters StreetEvents2 months ago

    Edited Transcript of STXS earnings conference call or presentation 6-Mar-18 3:00pm GMT

    Q4 2017 Stereotaxis Inc Earnings Call

  • GlobeNewswire3 months ago

    Stereotaxis Reports 2017 Fourth Quarter and Full Year Financial Results

    7% year-over-year growth in fourth quarter global procedures and recurring revenue Substantial progress in delineating and initiating strategic innovation plans Increasing quantity and quality of peer-reviewed ...

  • GlobeNewswire3 months ago

    Stereotaxis Announces $10.0 Million Non-Dilutive Financing from Early Warrant Exercise

    Enables continued execution of innovation and commercial initiatives Non-dilutive to shareholders Long term lock-up agreement on exercised warrants Represents necessary first step on path to relist on ...

  • ACCESSWIRE3 months ago

    The Story Behind Growth: New Report Discusses Stereotaxis and OurPet's Co. - Emerging Trends Within New Industry

    NEW YORK, NY / ACCESSWIRE / March 6, 2018 / Latest key findings by Growth Market Report for all traders, shareholders, and investors of Stereotaxis Inc. ( OTCQX: STXS ) and OurPet's Co. ( OTCQX: OPCO ), ...

  • GlobeNewswire3 months ago

    Stereotaxis to Report Fourth Quarter and Full Year 2017 Financial Results on March 6, 2018

    LOUIS, March 02, 2018-- Stereotaxis, Inc., a global leader in innovative robotic technologies for the treatment of cardiac arrhythmias, today announced that it will release financial results for its 2017 ...

  • Thomson Reuters StreetEvents6 months ago

    Edited Transcript of STXS earnings conference call or presentation 9-Nov-17 3:00pm GMT

    Q3 2017 Stereotaxis Inc Earnings Call

  • Stereotaxis, Inc. :STXS-US: Earnings Analysis: Q2, 2017 By the Numbers : October 6, 2017
    Capital Cube7 months ago

    Stereotaxis, Inc. :STXS-US: Earnings Analysis: Q2, 2017 By the Numbers : October 6, 2017

    Categories: Yahoo FinanceGet free summary analysis Stereotaxis, Inc. reports financial results for the quarter ended June 30, 2017. Highlights Summary numbers: Revenues of USD 8.47 million, Net Earnings of USD -0.18 million. Gross margins narrowed from 86.09% to 73.99% compared to the same period last year, operating (EBITDA) margins now -2.93% from -19.07%. Change in operating cash ... Read more (Read more...)